{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T15:58:30Z","timestamp":1792425510073,"version":"4.5.0"},"reference-count":25,"publisher":"Elsevier","isbn-type":[{"value":"9780443139956","type":"print"}],"license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["837004014"],"award-info":[{"award-number":["837004014"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024]]},"DOI":"10.1016\/bs.mcb.2023.05.008","type":"book-chapter","created":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T01:30:38Z","timestamp":1694741438000},"page":"33-50","source":"Crossref","is-referenced-by-count":3,"title":["Fully closed and automated enrichment of primary blood dendritic cells for cancer immunotherapy"],"prefix":"10.1016","member":"78","reference":[{"issue":"7","key":"10.1016\/bs.mcb.2023.05.008_bb0010","doi-asserted-by":"crossref","first-page":"e257","DOI":"10.1016\/S1470-2045(13)70585-0","article-title":"Clinical use of dendritic cells for cancer therapy","volume":"15","author":"Anguille","year":"2014","journal-title":"The Lancet Oncology"},{"key":"10.1016\/bs.mcb.2023.05.008_bb0015","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/cite.201200175","article-title":"Integrated clinical scale manufacturing system for cellular products derived by magnetic cell separation, centrifugation and cell culture","volume":"85","author":"Apel","year":"2013","journal-title":"Chemie Ingenieur Technik"},{"issue":"15","key":"10.1016\/bs.mcb.2023.05.008_bb0020","doi-asserted-by":"crossref","first-page":"4332","DOI":"10.1158\/0008-5472.CAN-15-1695","article-title":"Expansion of a BDCA1+CD14+ myeloid cell population in melanoma patients may attenuate the efficacy of dendritic cell vaccines","volume":"76","author":"Bakdash","year":"2016","journal-title":"Cancer Research"},{"issue":"36","key":"10.1016\/bs.mcb.2023.05.008_bb0025","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1200\/JCO.2009.23.4799","article-title":"Final version of 2009 AJCC melanoma staging and classification","volume":"27","author":"Balch","year":"2009","journal-title":"Journal of Clinical Oncology"},{"issue":"6673","key":"10.1016\/bs.mcb.2023.05.008_bb0030","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/32588","article-title":"Dendritic cells and the control of immunity","volume":"392","author":"Banchereau","year":"1998","journal-title":"Nature"},{"issue":"1","key":"10.1016\/bs.mcb.2023.05.008_bb0035","doi-asserted-by":"crossref","first-page":"2015113","DOI":"10.1080\/2162402X.2021.2015113","article-title":"Immunological responses to adjuvant vaccination with combined CD1c+ myeloid and plasmacytoid dendritic cells in stage III melanoma patients","volume":"11","author":"Bloemendal","year":"2022","journal-title":"Oncoimmunology"},{"key":"10.1016\/bs.mcb.2023.05.008_bb0040","doi-asserted-by":"crossref","first-page":"S732","DOI":"10.1016\/j.annonc.2020.08.1202","article-title":"1078MO MIND-DC: A randomized phase III trial to assess the efficacy of adjuvant dendritic cell vaccination in comparison to placebo in stage IIIB and IIIC melanoma patients","volume":"31","author":"Bol","year":"2020","journal-title":"Annals of Oncology"},{"issue":"1","key":"10.1016\/bs.mcb.2023.05.008_bb0045","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s40425-019-0580-6","article-title":"The clinical application of cancer immunotherapy based on naturally circulating dendritic cells","volume":"7","author":"Bol","year":"2019","journal-title":"Journal for Immunotherapy of Cancer"},{"issue":"4","key":"10.1016\/bs.mcb.2023.05.008_bb0050","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1189\/jlb.0105052","article-title":"Dendritic cells differentiated in the presence of IFN-beta and IL-3 are potent inducers of an antigen-specific CD8+ T cell response","volume":"78","author":"Breckpot","year":"2005","journal-title":"Journal of Leukocyte Biology"},{"issue":"11","key":"10.1016\/bs.mcb.2023.05.008_bb0055","doi-asserted-by":"crossref","first-page":"6037","DOI":"10.4049\/jimmunol.165.11.6037","article-title":"BDCA-2, BDCA-3, and BDCA-4: Three markers for distinct subsets of dendritic cells in human peripheral blood","volume":"165","author":"Dzionek","year":"2000","journal-title":"Journal of Immunology"},{"issue":"12","key":"10.1016\/bs.mcb.2023.05.008_bb0060","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1084\/jem.194.12.1823","article-title":"BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon alpha\/beta induction","volume":"194","author":"Dzionek","year":"2001","journal-title":"The Journal of Experimental Medicine"},{"issue":"2","key":"10.1016\/bs.mcb.2023.05.008_bb0065","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.eururo.2013.11.002","article-title":"EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer","volume":"65","author":"Heidenreich","year":"2014","journal-title":"European Urology"},{"issue":"6","key":"10.1016\/bs.mcb.2023.05.008_bb0070","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1084\/jem.20092140","article-title":"Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens","volume":"207","author":"Jongbloed","year":"2010","journal-title":"The Journal of Experimental Medicine"},{"issue":"12","key":"10.1016\/bs.mcb.2023.05.008_bb0075","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1084\/jem.20092720","article-title":"Mouse CD8alpha+ DCs and human BDCA3+ DCs are major producers of IFN-lambda in response to poly IC","volume":"207","author":"Lauterbach","year":"2010","journal-title":"The Journal of Experimental Medicine"},{"issue":"3","key":"10.1016\/bs.mcb.2023.05.008_bb0080","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0092-8674(01)00456-1","article-title":"Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity","volume":"106","author":"Liu","year":"2001","journal-title":"Cell"},{"issue":"13","key":"10.1016\/bs.mcb.2023.05.008_bb0085","doi-asserted-by":"crossref","first-page":"4512","DOI":"10.1182\/blood-2001-11-0097","article-title":"Characterization of human blood dendritic cell subsets","volume":"100","author":"MacDonald","year":"2002","journal-title":"Blood"},{"key":"10.1016\/bs.mcb.2023.05.008_bb0090","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1146\/annurev-immunol-020711-074950","article-title":"The dendritic cell lineage: Ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting","volume":"31","author":"Merad","year":"2013","journal-title":"Annual Review of Immunology"},{"issue":"6","key":"10.1016\/bs.mcb.2023.05.008_bb0095","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1182\/blood-2013-04-495424","article-title":"Human CD1c+ dendritic cells secrete high levels of IL-12 and potently prime cytotoxic T-cell responses","volume":"122","author":"Nizzoli","year":"2013","journal-title":"Blood"},{"issue":"4","key":"10.1016\/bs.mcb.2023.05.008_bb0100","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nrc3258","article-title":"Cancer immunotherapy via dendritic cells","volume":"12","author":"Palucka","year":"2012","journal-title":"Nature Reviews. Cancer"},{"issue":"1","key":"10.1016\/bs.mcb.2023.05.008_bb0105","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.immuni.2018.12.027","article-title":"Plasmacytoid dendritic cells: Development, regulation, and function","volume":"50","author":"Reizis","year":"2019","journal-title":"Immunity"},{"issue":"9","key":"10.1016\/bs.mcb.2023.05.008_bb0110","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1158\/1078-0432.CCR-15-2205","article-title":"Effective clinical responses in metastatic melanoma patients after vaccination with primary myeloid dendritic cells","volume":"22","author":"Schreibelt","year":"2016","journal-title":"Clinical Cancer Research"},{"issue":"6","key":"10.1016\/bs.mcb.2023.05.008_bb0115","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.4049\/jimmunol.170.6.3306","article-title":"IL-4 down-regulates anaphylatoxin receptors in monocytes and dendritic cells and impairs anaphylatoxin-induced migration in vivo","volume":"170","author":"Soruri","year":"2003","journal-title":"Journal of Immunology"},{"issue":"3","key":"10.1016\/bs.mcb.2023.05.008_bb0120","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1158\/0008-5472.CAN-12-2583","article-title":"Natural human plasmacytoid dendritic cells induce antigen-specific T-cell responses in melanoma patients","volume":"73","author":"Tel","year":"2013","journal-title":"Cancer Research"},{"issue":"1","key":"10.1016\/bs.mcb.2023.05.008_bb0125","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1186\/s40425-019-0787-6","article-title":"Blood-derived dendritic cell vaccinations induce immune responses that correlate with clinical outcome in patients with chemo-naive castration-resistant prostate cancer","volume":"7","author":"Westdorp","year":"2019","journal-title":"Journal for Immunotherapy of Cancer"},{"key":"10.1016\/bs.mcb.2023.05.008_bb0130","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3389\/fimmu.2014.00165","article-title":"Paradigm shift in dendritic cell-based immunotherapy: From in vitro generated monocyte-derived DCs to naturally circulating DC subsets","volume":"5","author":"Wimmers","year":"2014","journal-title":"Frontiers in Immunology"}],"container-title":["Methods in Cell Biology","Cell-based Cancer Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091679X23001085?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091679X23001085?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T07:54:40Z","timestamp":1756281280000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091679X23001085"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"ISBN":["9780443139956"],"references-count":25,"URL":"https:\/\/doi.org\/10.1016\/bs.mcb.2023.05.008","relation":{},"ISSN":["0091-679X"],"issn-type":[{"value":"0091-679X","type":"print"}],"subject":[],"published":{"date-parts":[[2024]]}}}